Table 4 Mean (M) and standard deviation (SD) of the percent reduction in migraine frequency for patients with MO: migraine without aura, MA: migraine with aura, and CM: chronic migraine
Drugs | Migraine diagnosis | M (%) | DS | Case number |
|---|---|---|---|---|
Beta-blockers | MO | 23.31 | 63.17 | 36 |
MO + MA | 12.50 | 17.68 | 2 | |
CM | 56.67 | 40.60 | 7 | |
Total | 28.02 | 59.72 | 45 | |
calcium channel blocker | MO | 34.04 | 40.41 | 139 |
MA | 56.25 | 61.87 | 2 | |
MO + MA | 44.40 | 38.54 | 9 | |
CM | 25.06 | 29.09 | 15 | |
Total | 34.05 | 39.51 | 165 | |
Antidepressants | MO | 26.93 | 43.49 | 245 |
MA | 20.45 | 36.63 | 5 | |
MO + MA | 22.09 | 56.62 | 17 | |
CM | 31.05 | 32.88 | 157 | |
Total | 28.18 | 40.37 | 424 | |
Integrators | MO | 25.88 | 54.23 | 57 |
MO + MA | 33.33 | 22.82 | 4 | |
CM | 27.92 | 24.25 | 3 | |
Total | 26.44 | 51.59 | 64 | |
Antiepileptics | MO | 18.51 | 56.06 | 149 |
MA | 56.59 | 34.73 | 5 | |
MO + MA | 22.87 | 58.33 | 22 | |
CM | 29.97 | 32.88 | 101 | |
Total | 23.70 | 49.05 | 276 | |
Sartans | MO | 22.35 | 57.85 | 21 |
MO + MA | 25.00 | 35.36 | 2 | |
CM | 16.45 | 23.65 | 13 | |
Total | 20.37 | 46.36 | 36 | |
Total | MO | 26.07 | 48.84 | 647 |
MA | 41.47 | 40.24 | 12 | |
MO + MA | 26.54 | 50.79 | 56 | |
CM | 30.31 | 32.64 | 295 | |
Total | 27.52 | 44.75 | 1011 |